Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 160

1.

Primate vascular responses to octimibate, a non-prostanoid agonist at the prostacyclin receptor.

Merritt JE, Brown AM, Bund S, Cooper DG, Egan JW, Hallam TJ, Heagerty AM, Hickey DM, Kaumann AJ, Keen M, et al.

Br J Pharmacol. 1991 Jan;102(1):260-6.

2.

Octimibate, a potent non-prostanoid inhibitor of platelet aggregation, acts via the prostacyclin receptor.

Merritt JE, Hallam TJ, Brown AM, Boyfield I, Cooper DG, Hickey DM, Jaxa-Chamiec AA, Kaumann AJ, Keen M, Kelly E, et al.

Br J Pharmacol. 1991 Jan;102(1):251-9.

3.

Functional and ligand binding studies suggest heterogeneity of platelet prostacyclin receptors.

Armstrong RA, Lawrence RA, Jones RL, Wilson NH, Collier A.

Br J Pharmacol. 1989 Jul;97(3):657-68.

4.

Relaxant actions of nonprostanoid prostacyclin mimetics on human pulmonary artery.

Jones RL, Qian YM, Wise H, Wong HN, Lam WL, Chan HW, Yim AP, Ho JK.

J Cardiovasc Pharmacol. 1997 Apr;29(4):525-35.

PMID:
9156364
5.

Octimibate inhibition of platelet aggregation: stimulation of adenylate cyclase through prostacyclin receptor activation.

Seiler S, Brassard CL, Arnold AJ, Meanwell NA, Fleming JS, Keely SL Jr.

J Pharmacol Exp Ther. 1990 Dec;255(3):1021-6.

PMID:
2175792
6.

Prostaglandin endoperoxide analogues which are both thromboxane receptor antagonists and prostacyclin mimetics.

Armstrong RA, Jones RL, MacDermot J, Wilson NH.

Br J Pharmacol. 1986 Mar;87(3):543-51.

7.

Characterization of the prostanoid receptors mediating constriction and relaxation of human isolated uterine artery.

Baxter GS, Clayton JK, Coleman RA, Marshall K, Sangha R, Senior J.

Br J Pharmacol. 1995 Sep;116(1):1692-6.

8.
11.
12.

Homologous desensitization of human platelet thromboxane A2/prostaglandin H2 receptors.

Okwu AK, Ullian ME, Halushka PV.

J Pharmacol Exp Ther. 1992 Jul;262(1):238-45.

PMID:
1378092
13.

Nonprostanoid prostacyclin mimetics. 4. Derivatives of 2-[3-[2-(4,5-diphenyl-2-oxazolyl)ethyl]phenoxy]acetic acid substituted alpha to the oxazole ring.

Meanwell NA, Rosenfeld MJ, Wright JJ, Brassard CL, Buchanan JO, Federici ME, Fleming JS, Gamberdella M, Hartl KS, Zavoico GB, et al.

J Med Chem. 1993 Nov 26;36(24):3871-83.

PMID:
8254619
14.

Competitive antagonism at thromboxane receptors in human platelets.

Armstrong RA, Jones RL, Peesapati V, Will SG, Wilson NH.

Br J Pharmacol. 1985 Mar;84(3):595-607.

15.

Comparison of inhibitory actions of prostacyclin and a new prostacyclin analogue on the aggregation of human platelet in whole blood.

Saniabadi AR, Belch JJ, Lowe GD, Barbenel JC, Forbes CD.

Haemostasis. 1987;17(3):147-53.

PMID:
2440771
16.
17.

EP4 prostanoid receptor-mediated vasodilatation of human middle cerebral arteries.

Davis RJ, Murdoch CE, Ali M, Purbrick S, Ravid R, Baxter GS, Tilford N, Sheldrick RL, Clark KL, Coleman RA.

Br J Pharmacol. 2004 Feb;141(4):580-5. Epub 2004 Jan 26.

18.
19.

(5Z)-carbacyclin discriminates between prostacyclin-receptors coupled to adenylate cyclase in vascular smooth muscle and platelets.

Corsini A, Folco GC, Fumagalli R, Nicosia S, Noe MA, Oliva D.

Br J Pharmacol. 1987 Jan;90(1):255-61.

20.

Supplemental Content

Support Center